WebApr 4, 2024 · Key Expected Earnings Data Earnings Summary For their last quarter, Citius Pharmaceuticals (CTXR) reported earnings of -$0.04 per share. This reflects a … WebEarnings Per Share: The trailing 12 months EPS from total operations is the bottom line income after all expenses, divided by the weighted average number of common shares …
Citius Pharmaceuticals - CTXR - Stock Price Today - Zacks
WebApr 10, 2024 · During five years of share price growth, American Electric Power Company achieved compound earnings per share (EPS) growth of 2.9% per year. This EPS growth is slower than the share price growth of 7% per year, over the same period. This suggests that market participants hold the company in higher regard, these days. WebMar 24, 2024 · Citius Pharmaceuticals (NASDAQ:CTXR) has a recorded net income of -$33.64 million. CTXR has generated -$0.18 earnings per share over the last four quarters. What is Citius Pharmaceuticals's EPS forecast for next year? Citius Pharmaceuticals's … fix it lancaster
CTXR Citius Pharmaceuticals Inc. Analyst Estimates & Rating – WSJ
WebMar 13, 2024 · Citius Pharmaceuticals, Inc. (CTXR) consensus earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts. … WebApr 13, 2024 · Citius Pharmaceuticals Inc. (NASDAQ:CTXR) shares, rose in value on Wednesday, 04/12/23, with the stock price up by 2.61% to the previous day’s close as strong demand from buyers drove the stock to $1.57. Actively observing the price movement in the last trading, the stock closed the session at $1.53, falling within a range of $1.48 … WebApr 4, 2024 · CTXR: Citius Pharmaceuticals Detailed Earnings Estimate. Get the latest Detailed Estimate from Zacks Investment Research. CTXR: Citius Pharmaceuticals - … cannabis investment opportunity